Add to ORKGMyelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker of demyelinating disease that is associated with recurrent CNS attacks. The optimal treatment to lower the risk of or prevent relapses is unknown. The goal of this study was to determine the efficacy of chronic immunotherapy in preventing relapse of MOG-IgG-positive demyelinating events
Anti-myelin oligodendrocyte glycoprotein antibodies have been associated with a wide range of clinic...
Serum monoclonal anti-myelin-associated glycoprotein antibodies may be pathogenic in some people wit...
BackgroundImmunotherapy has been shown to reduce relapses in patients with myelin oligodendrocyte gl...
Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker...
Background: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an important etiology of...
Background We evaluated the seroprevalence of myelin oligodendrocyte glycoprotein immunoglobulin G1 ...
Background: A considerable number of patients with myelin oligodendrocyte glycoprotein antibody–asso...
IMPORTANCE: Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effe...
Current treatments for antibody-mediated autoimmunity are associated with lack of specificity, leadi...
Myelin-Oligodendrocyte Glycoprotein (MOG) is an adhesive molecule responsible for myelin sheath stru...
Importance: Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effe...
BackgroundIgG antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) define a subset of as...
Current treatments for antibody-mediated autoimmunity are associated with lack of specificity, leadi...
Background Serum monoclonal anti-myelin associated glycoprotein antibodies may be pathogenic in som...
Introduction. The database contains information regarding patients with myelin oligodendrocyte glyco...
Anti-myelin oligodendrocyte glycoprotein antibodies have been associated with a wide range of clinic...
Serum monoclonal anti-myelin-associated glycoprotein antibodies may be pathogenic in some people wit...
BackgroundImmunotherapy has been shown to reduce relapses in patients with myelin oligodendrocyte gl...
Myelin oligodendrocyte glycoprotein autoantibody (MOG-IgG) is a recently established serum biomarker...
Background: Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is an important etiology of...
Background We evaluated the seroprevalence of myelin oligodendrocyte glycoprotein immunoglobulin G1 ...
Background: A considerable number of patients with myelin oligodendrocyte glycoprotein antibody–asso...
IMPORTANCE: Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effe...
Current treatments for antibody-mediated autoimmunity are associated with lack of specificity, leadi...
Myelin-Oligodendrocyte Glycoprotein (MOG) is an adhesive molecule responsible for myelin sheath stru...
Importance: Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effe...
BackgroundIgG antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) define a subset of as...
Current treatments for antibody-mediated autoimmunity are associated with lack of specificity, leadi...
Background Serum monoclonal anti-myelin associated glycoprotein antibodies may be pathogenic in som...
Introduction. The database contains information regarding patients with myelin oligodendrocyte glyco...
Anti-myelin oligodendrocyte glycoprotein antibodies have been associated with a wide range of clinic...
Serum monoclonal anti-myelin-associated glycoprotein antibodies may be pathogenic in some people wit...
BackgroundImmunotherapy has been shown to reduce relapses in patients with myelin oligodendrocyte gl...